Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retapamulin vs Linezolid for MRSA Skin Infections
NCT00852540Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of retapamulin in traumatic lesion, impetigo, sponsored by GSK. Started Apr 2009; status: completed.
02
Drugs
retapamulin
03
Conditions
traumatic lesionimpetigo
Beyond the preview
Go deeper on NCT00852540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00852540.